Focus Investment Banking

JULY 31, 2023

This article focuses on how medical practices are valued by private equity-backed groups, and to an extent, health systems and other strategic acquirers. Emergency medicine, radiology, and anesthesiology groups may also be candidates for acquisition by longer-established acquirers. We explore each in turn below.

Medical 52

Medical Private Equity Healthcare Professional Services 52

Sun Acquisitions

FEBRUARY 6, 2023

Sun Acquisitions is pleased to announce the successful sale of Return Logistics to Triumvirate Environmental Services. Domenic Rinaldi, Managing Director of Sun Acquisitions, noted, “It was a pleasure representing Brian and Francine Stenz on the sale of Return Logistics to Triumvirate Environmental.

Sale 52

Sale Acquisitions Mergers and Acquisitions Manufacturing 52

How2Exit

AUGUST 2, 2023

With over 15 years of experience in the technology industry, Kurt has a deep understanding of how technology applies to mergers and acquisitions. rn Summary: rn Kurt Stein discusses the role of technology, specifically artificial intelligence (AI), in mergers and acquisitions. Let's dive in.

Mergers and Acquisitions 130

Mergers and Acquisitions Mergers Acquisitions M&A 130

Software Equity Group

MARCH 26, 2024

While these are just a handful of reasons why PEs love SaaS companies , it’s no wonder that top PE firms continue to focus on SaaS acquisitions. Main Capital has made 215 total investments since its founding, with current assets under management (AUM) of $2.37B and an active portfolio of 47 firms, with a median valuation of $10.25M.

Private Equity 52

Private Equity Equities Investment Portfolio 52

Lake Country Advisors

SEPTEMBER 30, 2024

Thoroughly reviewing and verifying financial statements is essential to avoid unexpected setbacks and ensure your acquisition is based on a solid financial foundation. A clear illustration of this is in the healthcare industry, where compliance with HIPAA and medical licensing regulations is non-negotiable.

Business 52

Business Valuation Financial Statement Broker 52

Mergers and Inquisitions

NOVEMBER 1, 2023

The short answer to #1 is that healthcare private equity firms operate in specific verticals with stable-ish cash flows, such as healthcare services, nursing facilities, medical devices, equipment, and healthcare IT. Areas like healthcare services and medical devices are fairly generalist and follow standard accounting and valuation.

Private Equity 59

Private Equity Healthcare Equities Middle Market 59

Solganick & Co.

JANUARY 9, 2024

January 9, 2024 2023: A Year of Strategic Consolidation and Diversification In 2023, the Healthcare IT sector witnessed a significant transformation marked by strategic mergers and acquisitions (M&A).

Healthcare 52

Healthcare M&A IT Mergers and Acquisitions 52

InvestmentBank.com

DECEMBER 1, 2020

M&A Beat – US Health Services Q2 2020 M&A Beat is a quarterly update for CEO’s, CFO’s, Owner, Founders of lower middle-market ($10M-$100M Rev) companies, offering relevant details on mergers and acquisitions deal value, volume, valuation multiples and trends in their respective industry and vertical. acquisition.

M&A 52

M&A Investment Banking Investment Bank 52

Tyton Partners

FEBRUARY 3, 2025

This stability will also enhance valuation certainty, encouraging sellers who had been hesitant due to market volatility to re-enter the market. Additionally, strong economic growth is fueling demand for education and workforce development solutions, particularly in edtech, corporate training, and higher education services.

Education 52

Education Sale Investors Medical 52

Focus Investment Banking

MARCH 28, 2024

A typical ophthalmology PPM was founded in 2018 and has completed ten total acquisitions since (and thus, is now partnered with ten practices). Some PPMs have gotten very large, with partnerships across a broad geographic area and valuations likely north of $1B. We also see them being aggressive about acquisitions.

Private Equity 52

Private Equity Equities Valuation Acquisitions 52

Peak Frameworks

SEPTEMBER 19, 2023

company to hit a $1 trillion valuation , it directly benefited shareholders. This deep involvement requires them to understand: Shareholder Interests: To gauge the return on investment and determine the valuation of potential deals. Shareholders: are primarily concerned about financial returns.

Corporation 52

Corporation Private Equity Mergers and Acquisitions Corporate Finance 52

Cooley M&A

JANUARY 23, 2024

For example, in the biopharma space, AbbVie, Bristol Myers Squibb, AstraZeneca, and Roche each announced multiple big-ticket acquisitions in the fourth quarter – including Abbvie’s acquisition of ImmunoGen for $10.1 billion; Bristol Myer Squibb’s acquisition of RayzeBio for $4.1 billion and Cerevel Therapeutics for $8.7

M&A 52

M&A Mergers and Acquisitions Acquisitions Pharmaceutical 52

Cooley M&A

JANUARY 22, 2020

A wave of big-ticket transactions by global pharmaceutical companies drove life sciences M&A activity to its fourth-largest year on record in 2019, with aggregate deal value in the pharmaceutical, medical and biotech industry reaching $234.2 billion acquisition of The Medicines Company. Year of the Life Sciences Mega-Deals.

M&A 40

M&A Pharmaceutical Acquisitions Capital 40

Focus Investment Banking

DECEMBER 26, 2023

In particular, companies in the logistics space likely will enjoy an enhancer to valuation if they utilize cutting edge technology. Nevertheless, owners are still holding out for what they perceive as the higher valuations of the previous few years. Contact Bill at William.snow@focusbankers.com.

Private Equity 52

Private Equity M&A Equities Insurance 52

Sica Fletcher

JULY 1, 2020

Update on Private Equity and Insurance Brokerages In our ,, previous article , we reported that the COVID-19 pandemic had not diminished the pace of mergers and acquisitions transactions we are seeing in the insurance agency and brokerage sector. The number of transactions we are working on has not abated. We face a future of uncertainty.

Private Equity 52

Private Equity Insurance Debt Equities 52

How2Exit

MARCH 7, 2023

Ron Concept 1: Know The Risks of M&A When it comes to mergers and acquisitions (M&A), it is essential to understand the risks involved. For example, when researching a medical condition, it is important to ask the right questions to ensure that a person gets the best advice from their doctor.

M&A 130

M&A Investors Mergers and Acquisitions IT 130

Cooley M&A

JANUARY 25, 2023

Amid depressed valuations, biotechnology companies also saw an increasing number of demands from activist investors that in certain cases led to more deal activity. For example, the sale of Horizon Therapeutics to Amgen for approximately $28 billion was the third-largest all-cash transaction in the pharmaceutical sector in history.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Cooley M&A

FEBRUARY 8, 2018

No longer just “acquihires,” today’s innovation-driven acquisition is focused on talent retention. See ABA Private Target Mergers & Acquisitions Deal Point Study for 2016-2017. Second, the FTC continues to aggressively target pharmaceutical companies in connection with mergers and acquisitions. billion acquisition of Alere.

M&A 52

M&A Mergers and Acquisitions Mergers Negotiation 52

How2Exit

MARCH 2, 2023

He tried a medical website, local portals, computer networking, and websites. MORE COOL STUFF For investors passionate about business acquisition and anyone interested in buying a company to strategically expand, selling/exiting, or driving up your valuation, the new Acquisition Aficionado Magazine is a must-have resource.

Business 130

Business Book-building Sale IT 130

Growth Business

NOVEMBER 23, 2023

Despite investment in the first half of 2023 dropping to £4.6bn from 2022’s £10.8bn as a result of rising interest rates, high inflation, a decrease in valuations and geopolitical tensions globally, UK fintechs are still attracting more VC investment than all other EMEA fintechs combined, with a significant percentage coming from US investors.

Investment 111

Investment Funds Capital Business 111

Cooley M&A

JULY 10, 2017

In life sciences/medical technology transactions, buyers and sellers often use milestone-based and sometimes royalty-based contingent consideration to compensate sellers for assets that are in various stages of development from clinical- to development-stage to product commercialization. [1] Disclosure. earn-out rights). Subsequent transfer.

Securities 52

Securities IT Investors M&A 52

Cooley M&A

JANUARY 20, 2022

1] Major all-cash acquisitions have followed, such as Arena Pharmaceutical’s agreement to sell to Pfizer for $6.7 Midsize pharmaceutical buyers pursuing opportunistic acquisition strategies, with robust capital markets and high valuations having limited the pool of attractive assets available in recent years.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40

Cooley M&A

JANUARY 25, 2023

The year started off with a bang, with mega-deals such as Microsoft’s pending $69 billion acquisition of Activision Blizzard, Elon Musk’s $44 billion acquisition of Twitter and Broadcom’s pending $61 billion acquisition of VMware inked in quick succession. Tech M&A in 2022 was a tale of two halves. trillion. [2]

M&A 52

M&A Mergers and Acquisitions Private Equity Mergers 52

Sun Acquisitions

FEBRUARY 6, 2025

Chicago, IL January 31, 2025 Sun Acquisitions, a leading mergers and acquisitions firm, is pleased to announce the successful sale of Home Care Angels, an independently owned and operated non-medical home service agency to Avid Health at Home Illinois, LLC, a personalized in-home care organization that provides support to individuals of all ages.

Sale 71

Sale Acquisitions Mergers and Acquisitions Medical 71

Focus Investment Banking

FEBRUARY 11, 2025

McKessons acquisition of PRISM Vision Group is an important milestone for private equitys investments in optometry practices. PRISM was founded in 2018 with Quad-C Managements acquisition of NJ Retina, a large Retina practice in New Jersey. Since then, PRISM has partnered with more than 20 ophthalmology groups throughout the Northeast.

Private Equity 52

Private Equity Healthcare Equities Medical 52

Mergers and Inquisitions

MARCH 5, 2025

Biotech Hedge Funds Definition: Biotech hedge funds bet for or against public biopharmaceutical companies, typically based on catalysts such as clinical trial results, acquisitions, and liquidations; many funds focus on early-stage companies, but some also invest in platform companies, and some also make private-market investments.

Funds 64

Funds Healthcare Mergers and Acquisitions Valuation 64

Lake Country Advisors

FEBRUARY 14, 2025

The complexities of valuation, compliance, and buyer expectations vary across industries, making specialized knowledge essential. For example, a manufacturing business broker must assess the value of machinery, raw materials, and supply chain contracts to present an accurate valuation.

Broker 52

Broker Business Valuation Healthcare 52

Lake Country Advisors

NOVEMBER 26, 2024

Whether you’re an experienced investor or considering your first business acquisition, manufacturing businesses present unique advantages—from established revenue streams to substantial tangible assets and promising growth opportunities. Recognizing these trends helps investors choose a manufacturing business positioned for future growth.

Manufacturing 59

Manufacturing Business Investment Profitability 59

Focus Investment Banking

FEBRUARY 17, 2025

Many of those organizations are nearing their own recapitalization events and will seek add-ons to increase their valuations. We believe companies that show consistent growth, especially in patient and provider acquisition and retention, will enjoy the most competitive sale processes. The common theme is scalability.

Private Equity 52

Private Equity Healthcare Equities Investors 52

Focus Investment Banking

MARCH 7, 2025

As a result, we are seeing important shifts in deal structure, and in many respects, larger differences in EBITDA calculations, valuation, and how transaction proceeds are paid than we did historically. Different post-transaction compensation formulas will create different valuations. Some buyers have become more conservative.

Healthcare 52

Healthcare Private Equity Equities Professional Services 52

Lake Country Advisors

JANUARY 13, 2025

An M&A advisor is a specialized professional who guides businesses through the intricate mergers and acquisitions process. M&A advisors provide end-to-end services, ensuring precision in handling all aspects of a transactionfrom valuation to closing. What Is an M&A Advisor? Below are the critical roles they play.

Broker 52

Broker M&A Business Negotiation 52

Cooley M&A

JANUARY 22, 2025

billion acquisition of Alpine Immune; by contrast, there were eight US biotech acquisitions exceeding $5 billion in 2023. 2024 saw companies focusing on internal research and development, innovative partnerships, and targeted bolt-on asset acquisitions to bolster their pipelines. from 2023. [1]

M&A 64

M&A Mergers and Acquisitions Pharmaceutical Acquisitions 64

Cooley M&A

JANUARY 25, 2024

The higher interest rates escalated borrowing expenses, making mega-deals (deals valued at $5 billion or more) significantly more expensive, due to their heavy reliance on debt financing, and impacted valuation multiples with higher discount rates. For example, while the $7.3

M&A 52

M&A Mergers and Acquisitions Investment Government 52

Mergers and Inquisitions

MARCH 19, 2025

But customer acquisition costs via Google and Facebook ad campaigns have risen over time and eaten into margins, so building a brand is still difficult. To give a deal example, well look at Sycamores ~$24 billion acquisition of Walgreens , which had been a public company for almost 100 years.

Private Equity 59

Private Equity Retail Equities Mergers and Acquisitions 59

InvestmentBank.com

MAY 18, 2021

In 2012, 25% of senior citizens had to declare bankruptcy due to medical expenses or were forced to mortgage their residences. The healthcare industry is formed of numerous subsectors including pharmaceutical services, diagnostics, medical technologies, and managed healthcare.

Healthcare 40

Healthcare M&A Valuation Hospitality 40